Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Edaravone by Suzhou Auzone Biological Technology for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Edaravone is under clinical development by Suzhou Auzone Biological Technology and currently in Phase I for Amyotrophic Lateral Sclerosis. According...